Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 14/20 | 0.58 |
| ▸ | ESR1 | P03372 | 12/20 | 0.58 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 1/20 | 0.43 |
| ▸ | DRD1 | P21728 | 1/20 | 0.43 |
| ▸ | DRD5 | P21918 | 1/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
| ▸ | SOD1 | P00441 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29890280 | 1.00 | ESR2 (0.58) | ESR2ESR1NR3C1ALDH1A1LMNA | |
| SCHEMBL1495864 | 0.89 | ESR2 (0.51) | ESR2ESR1NR3C1ALDH1A1LMNA | |
| SCHEMBL30250372 | 0.89 | ESR2 (0.51) | ESR2ESR1NR3C1ALDH1A1LMNA | |
| SCHEMBL23422132 | 0.87 | ESR1 (0.48) | ESR2ESR1ALDH1A1LMNACYP3A4 | |
| SCHEMBL1495859 | 0.87 | ESR2 (0.54) | ESR2ESR1NR3C1ALDH1A1LMNA | |
| SCHEMBL4236973 | 0.86 | ALDH1A1 (0.49) | ESR2ESR1ALDH1A1LMNACYP3A4 | |
| SCHEMBL12014319 | 0.84 | DRD2 (0.47) | ESR2ESR1NR3C1ALDH1A1LMNA | |
| SCHEMBL13799465 | 0.80 | SRD5A1 (0.49) | — | |
| SCHEMBL215429 | 0.79 | ESR2 (0.53) | ESR2ESR1DRD2DRD1DRD5 | |
| SCHEMBL29646250 | 0.79 | ESR2 (0.53) | ESR2ESR1DRD2DRD1DRD5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3822299-B1 | BIO-BASED POLYCARBONATE ESTER RESIN FOR EYEGLASS FRAME | SK CHEMICALS CO LTD (KR) | 2026-02-18 | — | — | EP | claimed |
| US-12391795-B2 | Polymerizable composition, and copolycarbonate ester and method for producing same | SK CHEMICALS CO., LTD. (KR) | 2025-08-19 | — | — | US | claimed |
| CN-112955492-B | Gao Shengwu-based polycarbonates and process for producing the same | SK化学公司 | 2023-09-08 | — | — | CN | claimed |
| CN-113166383-A | Polymerizable composition, and copolycarbonate and method for producing same | SK化学公司 | 2021-07-23 | — | — | CN | claimed |
| CN-112424258-A | Bio-based polycarbonate resin for eyeglass frame | SK化学公司 | 2021-02-26 | — | — | CN | claimed |
| WO-2020085662-A1 | HIGHLY BIO-BASED POLYCARBONATE ESTER AND METHOD FOR PRODUCING SAME | 에스케이케미칼 주식회사 | 2020-04-30 | — | — | WO | claimed |
| WO-2020085686-A1 | POLYMERIZABLE COMPOSITION, AND COPOLYCARBONATE ESTER AND METHOD FOR PRODUCING SAME | 에스케이케미칼 주식회사 | 2020-04-30 | — | — | WO | claimed |
| EP-3822299-B1 | BIO-BASED POLYCARBONATE ESTER RESIN FOR EYEGLASS FRAME | SK CHEMICALS CO LTD (KR) | 2026-02-18 | — | — | EP | disclosed |
| US-12479834-B2 | Phenol compound or salt thereof | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2025-11-25 | — | — | US | disclosed |
| CN-112955492-B | Gao Shengwu-based polycarbonates and process for producing the same | SK化学公司 | 2023-09-08 | — | — | CN | disclosed |
| US-20230049402-A1 | NOVEL PHENOL COMPOUND OR SALT THEREOF | TAIHO PHARMACEUTICAL CO. LTD. (JP) | 2023-02-16 | — | — | US | disclosed |
| US-11479640-B2 | Bio-based polycarbonate ester resin for eyeglass frame | SK CHEMICALS CO., LTD. (KR) | 2022-10-25 | — | — | US | disclosed |
| EP-4067343-A1 | NOVEL PHENOL COMPOUND OR SALT THEREOF | Taiho Pharmaceutical Co., Ltd. (JP) | 2022-10-05 | — | — | EP | disclosed |
| US-20050037925-A1 | 3-phenoxy-4-pyridazinol derivatives and herbicide composition containing the same | SANKYO AGRO COMPANY, LIMITED (JP) | 2005-02-17 | — | — | US | disclosed |
| CN-1543455-A | 3-phenoxy-4-pyridazinol derivatives and herbicidal compositions containing the same | 三共农业株式会社 | 2004-11-03 | — | — | CN | disclosed |
| EP-1426365-A1 | 3-PHENOXY-4-PYRIDAZINOL DERIVATIVE AND HERBICIDE COMPOSITION CONTAINING THE SAME | Sankyo Agro Company, Limited (JP) | 2004-06-09 | — | — | EP | disclosed |
| EP-0088346-B1 | 2-AMINOMETHYL-PHENOL DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-06-05 | — | — | EP | disclosed |
| EP-0088346-A2 | 2-Aminomethyl-phenol derivatives, process for their preparation, their use and pharmaceutical compositions containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-09-14 | — | — | EP | disclosed |
| WO-1981002012-A1 | NEW 2-AMINO METHYL-6-HALOGENOPHENOLS,PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREOF | SANDOZ AG (CH) | 1981-07-23 | — | — | WO | disclosed |
| EP-0020301-A1 | Basically substituted phenols, process for their preparation, pharmaceutical preparations containing these compounds and their use | CIBA-GEIGY AG (CH) | 1980-12-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12479834-B2 | Phenol compound or salt thereof | REN, MLX, MYB | ESR2 1544/4885ESR1 324/4885NR3C1 180/4885 |
| US-20230049402-A1 | NOVEL PHENOL COMPOUND OR SALT THEREOF | MYB, MLX, EP300 | ESR2 1464/4885ESR1 383/4885NR3C1 270/4885 |
| US-20050037925-A1 | 3-phenoxy-4-pyridazinol derivatives and herbicide composition containing the same | CBR3, DDT, CHRM2 | ESR2 1700/4885ESR1 2410/4885NR3C1 318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.